145 related articles for article (PubMed ID: 36228164)
1. Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the Global Burden of Disease Study.
Cao G; Liu J; Liu M
Chin Med J (Engl); 2022 Sep; 135(17):2049-2055. PubMed ID: 36228164
[TBL] [Abstract][Full Text] [Related]
2. Global, Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019.
Cao G; Liu J; Liu M
J Epidemiol Glob Health; 2023 Jun; 13(2):344-360. PubMed ID: 37178451
[TBL] [Abstract][Full Text] [Related]
3. Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status.
Cao G; Jing W; Liu J; Liu M
Hepatol Int; 2022 Dec; 16(6):1282-1296. PubMed ID: 36048317
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.
GBD 2019 Europe Hepatitis B & C Collaborators
Lancet Public Health; 2023 Sep; 8(9):e701-e716. PubMed ID: 37633679
[TBL] [Abstract][Full Text] [Related]
5. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.
Liu Z; Mao X; Jiang Y; Cai N; Jin L; Zhang T; Chen X
Cancer Med; 2019 Sep; 8(12):5787-5799. PubMed ID: 31385465
[TBL] [Abstract][Full Text] [Related]
6. The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management.
Li Y; Ou Z; Yu D; He H; Zheng L; Chen J; Chen C; Xiong H; Chen Q
BMC Cancer; 2023 Jun; 23(1):598. PubMed ID: 37380957
[TBL] [Abstract][Full Text] [Related]
7. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention.
Cao G; Jing W; Liu J; Liu M
Hepatol Int; 2021 Oct; 15(5):1068-1082. PubMed ID: 34345993
[TBL] [Abstract][Full Text] [Related]
8. Assessing the impact of comorbid type 2 diabetes mellitus on the disease burden of chronic hepatitis B virus infection and its complications in China from 2006 to 2030: a modeling study.
Xie J; Wang X; Wang X; Li J; Jie Y; Hao Y; Gu J
Glob Health Res Policy; 2024 Jan; 9(1):5. PubMed ID: 38246986
[TBL] [Abstract][Full Text] [Related]
9. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.
Liu Z; Jiang Y; Yuan H; Fang Q; Cai N; Suo C; Jin L; Zhang T; Chen X
J Hepatol; 2019 Apr; 70(4):674-683. PubMed ID: 30543829
[TBL] [Abstract][Full Text] [Related]
10. [Burden of hepatitis B-associated diseases in China from 1990 to 2030].
Yao L; Lin S; Huang J; Wu Y
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Nov; 35(5):464-475. PubMed ID: 38148535
[TBL] [Abstract][Full Text] [Related]
11. [Analysis and prediction of disease burden of cirrhosis and other chronic liver diseases due to alcohol use in China from 1990 to 2030].
Zhu S; Chen ST; Jin YY; Lu SW; Zou FJ; Ma WJ; Zeng FF; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Feb; 45(2):185-191. PubMed ID: 38413055
[No Abstract] [Full Text] [Related]
12. Trend of the mortality of major liver diseases and its impact on life expectancy in China from 2006 to 2017.
Zhu J; Wang P; Ye H; Shi J; Wang X; Wang K; Duan F; Yang Q; Sun G; Zhang J
J Public Health (Oxf); 2022 Mar; 44(1):100-110. PubMed ID: 33454770
[TBL] [Abstract][Full Text] [Related]
13. Global, Regional, and National Incidence and Mortality of Neonatal Preterm Birth, 1990-2019.
Cao G; Liu J; Liu M
JAMA Pediatr; 2022 Aug; 176(8):787-796. PubMed ID: 35639401
[TBL] [Abstract][Full Text] [Related]
14. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
15. The impact of universal hepatitis B vaccine on the trend of liver cancer from the Global Burden of Disease Study 2017.
Li C; He WQ
Liver Int; 2021 Aug; 41(8):1762-1774. PubMed ID: 33590659
[TBL] [Abstract][Full Text] [Related]
16. Disease burden of viral hepatitis A, B, C and E: A systematic analysis.
Liu Z; Shi O; Zhang T; Jin L; Chen X
J Viral Hepat; 2020 Dec; 27(12):1284-1296. PubMed ID: 32741034
[TBL] [Abstract][Full Text] [Related]
17. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
[TBL] [Abstract][Full Text] [Related]
18. Disease Burden from Hepatitis B Virus Infection in Guangdong Province, China.
Xiao J; Lin H; Liu T; Zeng W; Li X; Shao X; Tan Q; Xu Y; Xu X; Zheng H; Ma W
Int J Environ Res Public Health; 2015 Nov; 12(11):14055-67. PubMed ID: 26540065
[TBL] [Abstract][Full Text] [Related]
19. Global Patterns and Trends in Total Burden of Hepatitis B from 1990 to 2019 and Predictions to 2030.
Zhang C; Liu Y; Zhao H; Wang G
Clin Epidemiol; 2022; 14():1519-1533. PubMed ID: 36540899
[TBL] [Abstract][Full Text] [Related]
20. The trends of mortality, aetiologies and risk factors of lower respiratory infections in China from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.
Kang L; Jing W; Liu Q; Liu J; Liu M
J Infect Public Health; 2022 Aug; 15(8):870-876. PubMed ID: 35797886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
